References
- Lande K, Gjesdal K, Fønstelien E, Kjeldsen S E, Eide I. Effects of adrenaline infusion on platelet number, volume and release reaction. Thromb Haemost 1985; 54: 450–3
- Lande K, Os I, Kjeldsen S E, Westhcim A, Hjermann I, Eide I, Gjesdal K. Increased platelet size and release reaction in essential hypertension. J Hypertens 1987; 5: 401–6
- Lande K, Kjeldsen S E, Os I, Westheim A, Hjermann I, Eide I, Gjesdal K. Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension. J Hypertens 1988; 6: 219–25
- Kjeldsen S E, Gjesdal K, Eide I, Aakesson I, Amundsen R, Foss O P, Lercn P. Increased beta-thromboglobulin in essential hypertension: Interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand 1983; 213: 369–73
- Kjeldsen S E, Lande K, Jackson M B, Westheim A, Frederichsen P, Leren P, Eide I. Increased plasma noradrenaline during severe sodium restriction does not stimulate platelet release in essential hypertension. Thromb Haemostas 1986; 56: 120–23
- Goldberg L I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 1972; 24: 1–29
- Braunstein K M, Kay E S, Kleinfelder J, Helen B S, Colwell J A, Eurenius K. The effects of dopamine on human platelet aggregation, in vitro. J Pharmacol Exp Ther 1977; 200: 449–57
- Kodaira H, Ishikawa M, Komoda Y, Nakajima T. Time-dependent inhibition of platelet aggregation by dopamine and 3-methoxytyramine. Important roles of their metabolites. Biochem Pharmacol 1984; 33: 435–41
- Roth J A, Rivett A J. Does sulphate conjugation contribute to the metabolic inactivation of catecholamines in humans?. Biochem Pharmacol 1982; 31: 3071–2
- Hart R F, Renkers K J, Nelson E B, Roth J A. Localization and characterization of phenol sul-fotransferase in human platelets. Life Sci 1979; 24: 125–30
- Da Prada M, Picotti G B. Content and subcellular localization of catecholamines and 5-hydroxy-tryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma. Br J Pharmac 1979; 65: 653–62
- Toth L A, Scott M C, Elchisaka M A. Dopamine sulfate formation and phenol sulfotransferase activity in dog and human platelets. Life Sci 1986; 39: 519–26
- Romain Y, Demassieux S, D'Angelo G, Gyger M, Carriere S. Is the platelet phenosulfotrans-ferase involved in the sulfoconj ligation of plasma catecholamines?. Can J Physiol Pharmacol 1986; 64: 1197–201
- Hassan M N, Reches A, Kuhn C, Higgins D, Fahn S. Pharmacologic evaluation of dompaminergic receptor blockade by metoclopramide. Clin Neuropharm 1986; 9: 71–8
- Stumpe K O, Kollock R, Higuchi M, Kruck F, Vetter H. Hyperprolactinemia and antihypertensive effect of bromocriptine in essential hypertension: identification of abnormal central dopamine control. Lancet 1977; 2: 211–4
- Kjeldsen S E, Flaaten B, Eide I, Helgeland A, Leren P, Fonstelien E. Decreased peripheral dopaminergic activity in essential hypertension?. Scand J Clin Lab Invest 1983; 43: 15–20
- Os I, Kjeldsen S E, Westheim A, Aakesson I, Norman N, Enger E, Hjermann I, Eide I. Decreased central dopaminergic activity in essential hypertension. J Hypertens 1987; 5: 191–7
- Goldberg L I. Dopamine receptors and hypertension. Physiologic and pharmacologic implications. Am J Med 1984; 77: 37–44
- Os I, Kjeldsen S E, Westheim A, Lande K, Norman N, Hjermann I, Eide I. Endocrine and haemodynamic responses to graded dopamine infusion in essential hypertension. Scand J Clin Lab Invest 1987; 47: 371–7
- Peuler J D, Johnson G A. Simultaneous single isotope radio-enzyme assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977; 21: 625–36
- Kjeldsen S E, Flaaten B, Eide I, Helgeland A, Leren P. Evidence of increased peripheral catecholamine release in patients with longstanding, untreated essential hypertension. Scand J Clin Lab Invest 1982; 42: 217–23
- Rutlin E, Haug E, Torjesen P A. Serum thyro-trophin, prolactin and growth hormone, response to TRH during oestrogen treatment. Acta Endocrinol 1977; 84: 23–35
- Brown B W, Hollander M. Statistics. A biomedical introduction. John Wiley, New York 1977; 310–39
- Conover W J. Practical Nonparametric Statistics, 2nd ed. John Wiley, New York 1980; 299–300
- MacLeod R M. Regulation of prolactin secretion. Frontiers in neuroendocrinology 1976; 4: 169–95
- Kaplan K L, Owen J. Plasma levels of platelet secretory proteins. CRC Critical Reviews in Oncology/Hematology 1986; 5: 235–55
- Bugiardini R, Chierchia S, Crea F, Gallino A, Wild S, Roskovec A, Lenzi S, Maseri A. Evaluation of the effects of catheter sampling for the study of platelet behavior in pulmonary and coronary circulation. Am Heart J 1984; 108: 255–60
- Karpatkin S. Heterogenity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 1978; 51(2)307–16
- Eldor A, Avitzour M, Or R, Hanna R, Penchas S. Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J 1982; 285: 397–400
- Thompson C B, Eaton K A, Princiotta S M, Rushin C A, Vareri C R. Size dependent platelet sub-populations: Relationship of platelet volume to ultrastructure, enzymatic activity and function. Br J Haematol 1982; 50: 509–19
- Bruschi G, Minari M, Bruschi M E, Tacinelli L, Milani B, Cavatorta A, Borghetti A. Similarities of essential and spontaneous hypertension. Volume and number of blood cells. Hypertension 1986; 8: 983–9
- Martin J F, Plumb J, Kilbey R S, Kishk Y T. Changes in volume and density of platelets in myocardial infarction. Br Med J 1983; 287: 456–9
- Cameron H A, Phillips R, Ibbotson R M, Carson P HM. Platelet size in myocardial infarction. Br Med J 1983; 287: 449–51
- Giles C. The platelet count and mean platelet volume. Br J Haematol 1981; 48: 31–7
- Trowbridge E A, Reardon D M, Hutchinson D, Pickering C. The routine measurement of platelet volume: a comparison of light-scattering and aperture-impedance technologies. Clin Phys Physiol Meas 1985; 6: 221–38
- Aster R H. Pooling of platelets in the spleen: Role in the pathogenesis of ‘hypersplenic’ thrombocytopenia. J Clin Invest 1966; 45: 645–57
- Thompson C B, Jokubowski J A. The pathophysiology and clinical relevance of platelet heterogeneity. Blood 1988; 72: 1–8
- De Keyser J, De Waele M, Convents A, Ebinger G, Vanquelin G. Identification of Drlike receptors on the human blood platelets. Life Scien 1988; 42: 1797–1806
- Altman D G. Statistics and ethics in medical research: 3 How Large a sample?. Br Med J 1980; 280: 1336–8